There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > ELISA Assay Kit > TIGIT > TAT-K004


For research use only.
Materials Provided
TAT-K004-C01Streptavidin pre-coated Plate 1plate
TAT-K004-C02Biotinylated TIGIT Protein10ug
TAT-K004-C03Human Anti-TIGIT antibody10ug
TAT-K004-C04HRP-anti-human IgG, Fc antibody10ug
TAT-K004-C05Diluent buffer50mL
  • Background
    TIGIT has been shown to be over expressed on tumor antigen-specific CD8+ T cells and CD8+ tumor infiltrating lymphocytes (TIL). Blockade of TIGIT led to increased cell proliferation, cytokine production, and degranulation of TA-specific CD8+ T cells and TIL CD8+ T cells, which now make it be considered as an immune checkpoint. Recently, studies have shown anti-TIGIT antibody is promising to become a cancer immunotherapy. Our ELISA kit is designed to help the discovery of anti-TIGIT therapeutic antibody.
  • Application
    It is for research use only.
  • Reconstitution
    See Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage

    Upon receipt, please store the lyophilized products at -20℃. After reconstitution, the stock solution should be kept at -70℃. Upon receipt, please store the plate at Room Temperature, and please store the buffer at -20℃.

    Try to avoid more than 3 freeze thaw cycles.

    No activity loss is observed after storage at: Room temperature (RT) for 1 month in lyophilized state; -20℃ for 1 year in lyophilized state; -70℃ for 6 months under sterile conditions after reconstitution.
  • Assay Principles
    This assay kit employs a standard Indirect-ELISA format, which provides a rapid quantification of Anti-TIGIT antibodies through antigen binding. The Kit includes of Streptavidin pre-coated plate, the Biotinylated TIGIT protein, a human anti-TIGIT antibody standard, a secondary HRP-anti-Human IgG, Fc antibody and an assay diluent.

    Your experiment will only have 5 simple steps:

    1. Coat the plate with Biotinylated TIGIT protein. Block and wash the plate.

    2. Add samples to the plate, and use human anti-TIGIT antibody as control. Incubate and wash the plate.

    3. Add the diluted secondary HRP-anti-human IgG, Fc antibody to the plate and incubate.

    4. Wash the plate and then add TMB or other colorimetric HRP substrate.

    5. Stop the substrate reaction by adding the diluted acid. Read OD at 450 nm, which reflects the amount of antibody bound.

Comments (0)

Order Details

Price(USD) : $680.00

Promotion & Exhibitions

Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:6 Details
  • Latest Research Phase:Phase ?

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.